We are looking for children aged 2 to 17 years to join a Crohn’s disease (CD) trial to help us discover more about treating ulcerative colitis (UC). If you are looking for a potential new treatment option for ulcerative colitis (UC) or IBD (including associated symptoms such as abdominal pain or cramping, diarrhea, abdominal pain, malnutrition and/or anemia), consider one of our IBD studies. All eligible participants will receive no-cost study-related care and study medication. Your children aged 2 to 17 years may be eligible to take part.
Your child may be eligible to take part in the IBD studies if they:
- are 2‒17 years of age
- have been diagnosed with moderate to severe ulcerative colitis (UC) or Crohn’s disease (CD)
- have previously received treatment for UC or CD that has not worked.
Find out if your child qualifies.
